Bank Of New York Mellon Corp My Md Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.92 - $96.0 $10,627 - $1.11 Million	11,552 New	11,552 $13,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $4.78 $1,334 - $3,188	-667 Reduced 5.69%	11,052 $24,000
Q4 2021 Feb 11, 2022	BUY	$5.46 - $9.69 $10 - $19	2 Added 0.02%	11,719 $71,000
Q3 2021 Nov 12, 2021	BUY	$4.64 - $7.94 $54,366 - $93,032	11,717 New	11,717 $84,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.